Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Drugs in Pipeline
13
Phase 3 Programs
5
Upcoming Catalysts
1
Next Catalyst
Dec 15, 2026
47wStock performance and market intelligence
2 upcoming, 1 past
For ophthalmic surgery. NDA filing. Extracted from SEC filing: 8-K
SourcePrimary completion for OMS906 study drug trial (NCT06298955) in Paroxysmal Nocturnal Hemoglobinuria
SourceMachine learning insights and smart money movement
Pending NDA/BLA submissions with predicted PDUFA dates
Clinical development programs and drug candidates
OMS103HP
Anterior Cruciate Ligament Reconstruction
OMS103HP-S
Meniscal Tear
Vehicle
Postoperative Pain
OMS302
Intraocular Lens Replacement
Phenylephrine HCl
Unilateral Cataract Extraction
OMS906 study drug
Paroxysmal Nocturnal Hemoglobinuria
Biological: narsoplimab
Thrombotic Microangiopathies
OMS302-PE
Cataract Extraction
OMS906
Paroxysmal Nocturnal Hemoglobinuria
OMS201
Urinary Calculi
OMS643762
Schizophrenia
OMS302 Solution
Cataract
OMS721
Thrombotic Microangiopathies
| Drug Name | Phase | Indication | Designations |
|---|---|---|---|
OMS103HP | Phase 3 | Anterior Cruciate Ligament Reconstruction | - |
OMS103HP-S | Phase 3 | Meniscal Tear | - |
Vehicle | Phase 3 | Postoperative Pain | - |
OMS302 | Phase 3 | Intraocular Lens Replacement | - |
Phenylephrine HCl | Phase 3 | Unilateral Cataract Extraction | - |
OMS906 study drug | Phase 2 | Paroxysmal Nocturnal Hemoglobinuria | - |
Biological: narsoplimab | Phase 2 | Thrombotic Microangiopathies | - |
OMS302-PE | Phase 2 | Cataract Extraction | - |
OMS906 | Phase 2 | Paroxysmal Nocturnal Hemoglobinuria | - |
OMS201 | Phase 2 | Urinary Calculi | - |
OMS643762 | Phase 2 | Schizophrenia | - |
OMS302 Solution | Phase 2 | Cataract | - |
OMS721 | Phase 2 | Thrombotic Microangiopathies | - |
Approvals, filings, and latest developments